Elanco Animal Health CFO Departs; Interim Appointed
Ticker: ELAN · Form: 8-K · Filed: May 28, 2025 · CIK: 1739104
| Field | Detail |
|---|---|
| Company | Elanco Animal Health Inc (ELAN) |
| Form Type | 8-K |
| Filed Date | May 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, cfo-departure, interim-appointment
Related Tickers: ELAN
TL;DR
Elanco's CFO, Todd Young, is out. Oliver Godres is interim CFO. Search for permanent replacement underway.
AI Summary
Elanco Animal Health Incorporated announced on May 21, 2025, the departure of its Chief Financial Officer, Todd M. Young. The company has appointed Oliver G. Godres as the interim CFO. This change is effective immediately, and the company has initiated a search for a permanent CFO.
Why It Matters
A sudden departure of a CFO can signal internal challenges or strategic shifts, potentially impacting investor confidence and the company's financial direction.
Risk Assessment
Risk Level: medium — The departure of a CFO, especially without immediate permanent replacement, can create uncertainty regarding financial strategy and leadership stability.
Key Players & Entities
- Elanco Animal Health Incorporated (company) — Registrant
- Todd M. Young (person) — Departing Chief Financial Officer
- Oliver G. Godres (person) — Interim Chief Financial Officer
- May 21, 2025 (date) — Effective date of CFO departure
FAQ
Who is the new interim Chief Financial Officer for Elanco Animal Health?
Oliver G. Godres has been appointed as the interim Chief Financial Officer.
When was the departure of the previous CFO effective?
The departure of Todd M. Young was effective May 21, 2025.
Has Elanco Animal Health appointed a permanent CFO?
No, the company has initiated a search for a permanent CFO.
What is Elanco Animal Health's principal executive office address?
The address is 2500 Innovation Way, Greenfield, Indiana 46140.
What is the SEC file number for Elanco Animal Health?
The SEC file number is 001-38661.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 28, 2025 by Todd M. Young regarding Elanco Animal Health Inc (ELAN).